20 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
LeMaitre Vascular Inc (LMAT) operates in the MEDICAL INSTRUMENTS & SUPPLIES industry and is headquartered in Burlington, United States with about 646 employees. Its market capitalization is roughly $2 billion. In the fiscal year ended 2025-12-31, LMAT reported $250M in revenue and $58M in net income.
LeMaitre Vascular, Inc. develops, manufactures, and markets medical devices and implants used in the field of vascular surgery in the Americas, Europe, the Middle Esat, Africa, and the Asia Pacific.
Interactive charts & full statements → Open the LMAT valuation workbench →
| Income statement | TTM → 2026-06-30 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 | 2013-12-31 | 2012-12-31 | 2011-12-31 | 2010-12-31 | 2009-12-31 | 2008-12-31 | 2007-12-31 | 2006-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $262M | $250M | $220M | $193M | $162M | $154M | $129M | $117M | $106M | $101M | $89M | $78M | $71M | $65M | $57M | $58M | $56M | $51M | $49M | $41M | $35M |
| Gross Profit | $191M | $179M | $151M | $127M | $105M | $101M | $85M | $80M | $74M | $71M | $63M | $54M | $48M | $45M | $41M | $40M | $42M | $37M | $34M | $31M | $25M |
| Gross Margin % | 72.9% | 71.5% | 68.6% | 65.7% | 64.9% | 65.6% | 65.4% | 68.1% | 70.0% | 70.1% | 70.6% | 69.1% | 68.1% | 69.9% | 72.0% | 69.7% | 74.4% | 73.3% | 69.6% | 74.1% | 73.0% |
| Operating Income (EBIT) | $77M | $68M | $52M | $37M | $27M | $36M | $29M | $21M | $28M | $21M | $16M | $12M | $6M | $5M | $4M | $4M | $4M | $2M | ($3M) | ($4M) | ($1M) |
| Operating Margin % | 29.5% | 27.2% | 23.8% | 19.0% | 16.6% | 23.6% | 22.2% | 18.1% | 26.7% | 20.9% | 18.3% | 14.7% | 8.9% | 7.0% | 7.5% | 6.4% | 7.2% | 3.8% | -6.0% | -10.3% | -2.0% |
| Net Income | $66M | $58M | $44M | $30M | $21M | $27M | $21M | $18M | $23M | $17M | $11M | $8M | $4M | $3M | $3M | $2M | $6M | $2M | ($3M) | ($3M) | ($1M) |
| Net Margin % | 25.0% | 23.1% | 20.0% | 15.6% | 12.8% | 17.4% | 16.4% | 15.3% | 21.7% | 17.0% | 11.9% | 9.9% | 5.5% | 5.0% | 4.5% | 3.7% | 10.7% | 3.1% | -6.8% | -7.1% | -3.4% |
| EBITDA | $97M | $91M | $67M | $49M | $37M | $46M | $37M | $27M | $33M | $25M | $20M | $15M | $10M | $7M | $6M | $6M | $5M | $4M | ($1M) | ($1M) | $1M |
| Earnings Per Share (EPS) | $2.77 | $2.52 | $1.93 | $1.34 | $0.93 | $1.25 | $1.04 | $0.88 | $1.13 | $0.86 | $0.55 | $0.42 | $0.23 | $0.20 | $0.16 | $0.13 | $0.37 | $0.10 | $-0.21 | $-0.19 | $-0.12 |
| Shares Outstanding (M) | 25M | 23M | 23M | 22M | 22M | 21M | 20M | 20M | 20M | 20M | 19M | 18M | 17M | 16M | 16M | 16M | 16M | 16M | 16M | 15M | 10M |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | $70M | $67M | $64M | $61M | $64M | $60M | $56M | $55M |
| Gross Profit | $51M | $48M | $46M | $46M | $45M | $41M | $39M | $37M |
| Gross Margin % | 72.1% | 72.7% | 71.7% | 75.3% | 70.0% | 69.2% | 69.3% | 67.8% |
| Operating Income (EBIT) | $20M | $18M | $19M | $20M | $16M | $13M | $13M | $13M |
| Operating Margin % | 29.0% | 26.7% | 29.2% | 33.3% | 25.1% | 21.1% | 23.1% | 24.0% |
| Net Income | $17M | $16M | $16M | $17M | $14M | $11M | $11M | $11M |
| Net Margin % | 24.2% | 23.6% | 24.2% | 28.4% | 21.4% | 18.4% | 20.1% | 20.3% |
| EBITDA | $23M | $24M | $24M | $26M | $22M | $18M | $20M | $17M |
| Earnings Per Share (EPS) | $0.70 | $0.68 | $0.68 | $0.71 | $0.60 | $0.48 | $0.49 | $0.49 |
| Shares Outstanding (M) | 25M | 23M | 23M | 24M | 23M | 23M | 23M | 23M |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Cash flow | TTM → 2026-06-30 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 | 2013-12-31 | 2012-12-31 | 2011-12-31 | 2010-12-31 | 2009-12-31 | 2008-12-31 | 2007-12-31 | 2006-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from Operations (CFO) | $83M | $81M | $44M | $37M | $25M | $35M | $35M | $14M | $20M | $23M | $17M | $11M | $6M | $5M | $5M | $3M | $7M | $5M | $1M | ($2M) | ($1M) |
| Capital Expenditures (CapEx) | $9M | $7M | $7M | $7M | $3M | $5M | $3M | $4M | $3M | $6M | $3M | $2M | $1M | $3M | $1M | $2M | $3M | $2M | $1M | $1M | $1M |
| Free Cash Flow (FCF) | $74M | $74M | $37M | $29M | $22M | $30M | $32M | $10M | $16M | $16M | $14M | $9M | $4M | $2M | $3M | $1M | $4M | $4M | $0M | ($3M) | ($1M) |
| FCF Margin % | 28.1% | 29.8% | 16.9% | 15.2% | 13.7% | 19.6% | 24.6% | 8.9% | 15.6% | 16.3% | 15.8% | 11.7% | 6.1% | 3.9% | 6.0% | 1.9% | 8.0% | 7.5% | -0.3% | -7.8% | -4.3% |
| Dividends Paid | $20M | $18M | $14M | $12M | $11M | $9M | $8M | $7M | $5M | $4M | $3M | $3M | $2M | $2M | $2M | $1M | — | — | $0M | — | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly cash flow | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|---|---|---|---|
| Cash from Operations (CFO) | $16M | $15M | $23M | $29M | $20M | $9M | $15M | $14M |
| Capital Expenditures (CapEx) | $2M | $3M | $2M | $2M | $1M | $1M | $2M | $2M |
| Free Cash Flow (FCF) | $14M | $12M | $21M | $26M | $19M | $8M | $13M | $13M |
| FCF Margin % | 19.4% | 18.5% | 33.2% | 43.4% | 29.5% | 12.8% | 23.6% | 22.9% |
| Dividends Paid | $6M | $6M | $5M | $5M | $5M | $5M | $4M | $4M |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2026-06-30 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 | 2013-12-31 | 2012-12-31 | 2011-12-31 | 2010-12-31 | 2009-12-31 | 2008-12-31 | 2007-12-31 | 2006-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $641M | $616M | $552M | $347M | $310M | $293M | $253M | $188M | $153M | $126M | $102M | $91M | $81M | $70M | $63M | $60M | $63M | $57M | $54M | $61M | $57M |
| Cash & Cash Equivalents | $27M | $28M | $26M | $24M | $19M | $14M | $27M | $12M | $26M | $19M | $24M | $27M | $19M | $15M | $16M | $20M | $23M | $23M | $16M | $7M | $15M |
| Total Liabilities | $220M | $222M | $215M | $49M | $42M | $39M | $80M | $40M | $23M | $17M | $14M | $13M | $13M | $14M | $10M | $8M | $11M | $9M | $9M | $13M | $6M |
| Total Debt (Short + Long-Term) | $173M | $172M | $170M | $2M | $2M | $2M | $40M | $2M | $3M | $0M | $0M | $0M | $0M | $0M | $0M | $0M | $0M | $0M | $0M | $0M | $0M |
| Total Shareholders' Equity | $420M | $394M | $337M | $298M | $268M | $254M | $173M | $148M | $130M | $110M | $88M | $78M | $68M | $57M | $53M | $52M | $52M | $48M | $46M | $49M | $51M |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive LMAT viewer.
About TickerBase · Data methodology & sources · Privacy · Terms